Production of Monoclonal Antibodies in Plants for Cancer Immunotherapy
Joint Authors
Moussavou, Ghislain
Ko, Kisung
So, Yangkang
Choo, Young-Kug
Source
Issue
Vol. 2015, Issue 2015 (31 Dec. 2015), pp.1-9, 9 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2015-10-15
Country of Publication
Egypt
No. of Pages
9
Main Subjects
Abstract EN
Plants are considered as an alternative platform for recombinant monoclonal antibody (mAb) production due to the improvement and diversification of transgenic techniques.
The diversity of plant species offers a multitude of possibilities for the valorization of genetic resources.
Moreover, plants can be propagated indefinitely, providing cheap biomass production on a large scale in controlled conditions.
Thus, recent studies have shown the successful development of plant systems for the production of mAbs for cancer immunotherapy.
However, their several limitations have to be resolved for efficient antibody production in plants.
American Psychological Association (APA)
Moussavou, Ghislain& Ko, Kisung& So, Yangkang& Choo, Young-Kug. 2015. Production of Monoclonal Antibodies in Plants for Cancer Immunotherapy. BioMed Research International،Vol. 2015, no. 2015, pp.1-9.
https://search.emarefa.net/detail/BIM-1054980
Modern Language Association (MLA)
Moussavou, Ghislain…[et al.]. Production of Monoclonal Antibodies in Plants for Cancer Immunotherapy. BioMed Research International No. 2015 (2015), pp.1-9.
https://search.emarefa.net/detail/BIM-1054980
American Medical Association (AMA)
Moussavou, Ghislain& Ko, Kisung& So, Yangkang& Choo, Young-Kug. Production of Monoclonal Antibodies in Plants for Cancer Immunotherapy. BioMed Research International. 2015. Vol. 2015, no. 2015, pp.1-9.
https://search.emarefa.net/detail/BIM-1054980
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1054980
